arrow
P

Paola Monti

University of Oregon
H指数:25
被引数:1,785

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study

MicroRNA分析作为慢性淋巴细胞白血病首次治疗时间的预测指标: 来自O-CLL1前瞻性研究的见解

2024-08-230
OAAI
Genes selection using deep learning and explainable artificial intelligence for chronic lymphocytic leukemia predicting the need and time to therapy
2023-08-315
OAAI
MiR-146b-5p regulates IL-23 receptor complex expression in chronic lymphocytic leukemia cells

MiR-146b-5p调节慢性淋巴细胞白血病细胞中IL-23受体复合物的表达

2022-10-138
OAAI
The spectrum of subclonal TP53 mutations in chronic lymphocytic leukemia: A next generation sequencing retrospective study

慢性淋巴细胞白血病中亚克隆TP53突变谱: 下一代测序回顾性研究

2022-08-183
OAAI
In uveal melanoma Gα-protein GNA11 mutations convey a shorter disease-specific survival and are more strongly associated with loss of BAP1 and chromosomal alterations than Gα-protein GNAQ mutations
2022-07-0114
OAAI
Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials

依鲁替尼作为慢性淋巴细胞白血病患者一线治疗的有效性及与利妥昔单抗-苯达莫司汀的间接比较: 临床试验以外的486例研究结果

2021-05-033
OAAI
Antitumor Effects of PRIMA-1 and PRIMA-1Met (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?

PRIMA-1和PRIMA-1Met (APR246) 在血液系统恶性肿瘤中的抗肿瘤作用: 仍然是突变的P53-Dependent事件?

CELLS
IF5.2
2021-01-0729
OAAI
Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients

慢性淋巴细胞白血病的首次治疗时间和P53功能障碍: 早期患者的O-CLL1研究结果

2020-10-2812
OAAI
TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors

慢性淋巴细胞白血病中的TP53功能障碍: b细胞受体和BCL-2抑制剂时代的临床相关性

2020-06-2712
OAAI
NEAT1 Long Isoform Is Highly Expressed in Chronic Lymphocytic Leukemia Irrespectively of Cytogenetic Groups or Clinical Outcome

NEAT1长同种型在慢性淋巴细胞白血病中高表达,与细胞遗传学组或临床结果不同

2020-03-1310
OAAI